Eagan, Minnesota – October 15, 2026 -- Solventum (NYSE: SOLV) will release its third-quarter fiscal 2026 financial results on Thursday, November 5, 2026, after U.S. financial markets close.

Management hosts webcast directly after the November 5 release

Solventum management will hold a webcast following the release to discuss the results. The company said other forward-looking and material information may also be covered during the call, so the session may go beyond the reported figures.

St. Paul – October 12, 2026 -- Solventum (NYSE: SOLV) will take part in a virtual fireside chat at the 2026 KeyBanc Healthcare Forum on Wednesday, March 18, 2026, starting at approximately 10:30 a.m. EDT.

Solventum management will appear in a virtual format at the investor event

The session is a fireside chat, a Q&A-style discussion, and will be held online rather than in person. The company has not named which executives will take part.

A live webcast and a replay will be available through the investor relations site at investors.solventum.com.

Eagan – October 12, 2026 -- Solventum (NYSE: SOLV) will publish its second quarter fiscal 2026 financial results on Wednesday, August 5, 2026, after U.S. financial markets close.

Management to host webcast after the release

Solventum management will hold a webcast following the release to discuss the results. The company said other forward-looking and material information may also be covered during the call, so the session could contain disclosures beyond the quarterly figures.

Eagan, Minn. – October 12, 2026 -- Solventum (NYSE: SOLV) said it intends to separate its Health Information Systems business, a healthcare software unit with $1.4 billion in annual sales, and is targeting completion within 12 to 18 months.

The move is the latest step in the company's three-phase transformation strategy. Solventum's Board of Directors and management expect the separation to leave a dedicated MedTech company focused on its MedSurg and Dental Solutions businesses.

Eagan, Minn. – October 12, 2026 -- Solventum raised its full-year 2026 adjusted EPS guidance to $7.10-$7.20 and announced its intent to separate its Health Information Systems business, after second-quarter organic sales rose 9.5%.

Eagan, Minnesota – October 12, 2026 -- Solventum (NYSE: SOLV) will present at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, with management taking part in a fireside chat beginning at approximately 10:15 a.m. EDT in Boston, Massachusetts.

Solventum management gets a 10:15 a.m. EDT slot in Boston on Sept. 9

The company announced the appearance on Sept. 2, 2026, one week before the session. The announcement did not name the executives who will take part or list agenda topics.

Delray Beach, Fla. – – September 15, 2026 -- The global Revenue Cycle Management market is projected to reach USD 132.06 billion by 2031, up from USD 73.61 billion in 2026, expanding at a compound annual growth rate of 12.4%, according to MarketsandMarkets.